ProfileGDS5822 / ILMN_1228667
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 50% 58% 59% 64% 55% 63% 57% 38% 40% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 121.950
GSM1276600PDAC Late Ablation Control 229.558
GSM1276601PDAC Late Ablation Control 331.259
GSM1276602PDAC Late Ablation 131.764
GSM1276603PDAC Late Ablation 226.655
GSM1276604PDAC Late Ablation 336.663
GSM1303940PDAC Late Ablation_anti-CTLA4 126.357
GSM1303941PDAC Late Ablation_anti-CTLA4 218.238
GSM1303942PDAC Late Ablation_anti-CTLA4 319.140